Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Bhavsar, Pankaj K ^a   Levy, Bruce D ^b   Hew, Mark J ^a   Pfeffer, Michael A ^b   Kazani, Shamsah ^b   Israel, Elliot ^b   Chung, Kian F ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; DEXAMETHASONE; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOXIN A; SALBUTAMOL; AUTACOID; CORTICOSTEROID; LIPOXIN;

ADULT; ARTICLE; ASTHMA; BIOSYNTHESIS; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBEROPTIC BRONCHOSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MALE; PROTEIN SYNTHESIS; BRONCHOSCOPY; CASE CONTROL STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME IMMUNOASSAY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHOSCOPY; CASE-CONTROL STUDIES; DEXAMETHASONE; DOWN-REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; LIPOXINS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77956689713     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-71     Document Type: Article

References (42)

1. Stirling RG, Chung KF. Severeasthma: definition and mechanisms. Allergy 2001, 56:825-840. 10.1034/j.1398-9995.2001.00143.x, 11551247.
2. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M, Hussain I, Jarjour NN, Israel E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA, Busse WW, Wenzel SE. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:405-413. 10.1016/j.jaci.2006.11.639, 2837934, 17291857.
3. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
4. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics. Am J Respir Crit Care Med 1999, 160:1001-1008.
5. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008, 63:784-790. 10.1136/thx.2007.090027, 18492738.
6. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Fan Chung K, . National Heart Lung and Blood Institute's Severe Asthma Research Program Relative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe Asthma. Am J Respir Crit Care Med 2006, 174:134-141. 10.1164/rccm.200512-1930OC, 2662905, 16614347, National Heart Lung and Blood Institute's Severe Asthma Research Program.
7. Chung KFBP. Cytokines in asthma. Thorax 1999, 54:825-857. 10.1136/thx.54.9.825, 1745579, 10456976.
8. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002, 8:1018-1023. 10.1038/nm748, 12172542.
9. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E, . Severe Asthma Research Program NHLaBI Diminished Lipoxin Biosynthesis in Severe Asthma. Am J Respir Crit Care Med 2005, 172:824-830. 10.1164/rccm.200410-1413OC, 2718403, 15961693, Severe Asthma Research Program NHLaBI.
10. Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, BUSSE WW, Wenzel SE, Levy BD, . NHLBI Severe Asthma Research Program (SARP) Airway Lipoxin A4 Generation and Lipoxin A4 Receptor Expression Are Decreased in Severe Asthma. Am J Respir Crit Care Med 2008, 178:574-582. 10.1164/rccm.200801-061OC, 2542432, 18583575, NHLBI Severe Asthma Research Program (SARP).
11. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003, 22:478-483. 10.1183/09031936.03.00017003, 14516138.
12. Proceedings of the ATS Workshop on Refractory Asthma. Current Understanding, Recommendations, and Unanswered Questions. Am J Respir Crit Care Med 2000, 162:2341-2351.
13. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 1993, 92:1572-1579. 10.1172/JCI116738, 288306, 8376607.
14. Nassar GM, Morrow JD, Roberts LJ, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 1994, 269:27631-27634.
15. Profita M, Sala A, Siena L, Henson PM, Murphy RC, Paterno A, Bonanno A, Riccobono L, Mirabella A, Bonsignore G, Vignola AM. Leukotriene B4 Production in Human Mononuclear Phagocytes Is Modulated by Interleukin-4-Induced 15-Lipoxygenase. J Pharmacol Exp Ther 2002, 300:868-875. 10.1124/jpet.300.3.868, 11861792.
16. Chavis C, Godard P, de Crastes Paulet A, Damon M. Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells. Eicosanoids 1992, 5:203-211.
17. Serhan CN. Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways. Annual Review of Immunology 2007, 25:101-137. 10.1146/annurev.immunol.25.022106.141647, 17090225.
18. Çelik GE, Erkekol FO, Misirligil Z, Melli M. Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin Exp Allergy 2007, 37:1494-1501.
19. Wenzel S, Szefler S, Leung D, Sloan S, Rex M, Martin R. Bronchoscopic Evaluation of Severe Asthma. Persistent Inflammation Associated with High Dose Glucocorticoids. Am J Respir Crit Care Med 1997, 156:737-743.
20. Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, Chanez P. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 2005, 115:55-60. 10.1016/j.jaci.2004.09.038, 15637547.
21. Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P. Lipoxins Are Potential Endogenous Antiinflammatory Mediators in Asthma. Am J Respir Crit Care Med 2002, 165:1531-1535. 10.1164/rccm.200201-053OC, 12045128.
22. Aderem AACDWSCZ. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 1986, 164:179.
23. Suzuki K, Yamamoto T, Sato A, Murayama T, Amitani R, Yamamoto K, Kuze F. Lipopolysaccharide primes human alveolar macrophages for enhanced release of superoxide anion and leukotriene B4: self-limitations of the priming response with protein synthesis. Am J Respir Cell Mol Biol 1993, 8:500-508.
24. Coffey MJ, Phare SM, Peters-Golden M. Prolonged Exposure to Lipopolysaccharide Inhibits Macrophage 5-Lipoxygenase Metabolism Via Induction of Nitric Oxide Synthesis. J Immunol 2000, 165:3592-3598.
25. Brock TG, McNish RW, Mancuso P, Coffey MJ, Peters-Golden M. Prolonged lipopolysaccharide inhibits leukotriene synthesis in peritoneal macrophages: mediation by nitric oxide and prostaglandins. Prostaglandins Other Lipid Mediat 2003, 71:131-145. 10.1016/S1098-8823(03)00036-4, 14518557.
26. Huynh ML, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, Wenzel SE. Defective Apoptotic Cell Phagocytosis Attenuates Prostaglandin E2 and 15-Hydroxyeicosatetraenoic Acid in Severe Asthma Alveolar Macrophages. Am J Respir Crit Care Med 2005, 172:972-979. 10.1164/rccm.200501-035OC, 16040786.
27. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001, 2:612-619. 10.1038/89759, 11429545.
28. Brezinski ME, Serhan CN. Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc Natl Acad Sci USA 1990, 87:6248-6252. 10.1073/pnas.87.16.6248, 54510, 2117277.
29. Balter MS, Eschenbacher WL, Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am Rev Respir Dis 1988, 138:1134-1142.
30. Wenzel SE, Trudeau JB, Westcott JY, Beam WR, Martin RJ. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol 1994, 94:870-881. 10.1016/0091-6749(94)90155-4, 7963156.
31. Damon M, Chavis C, Daures JP, Crastes D, Michel FB, Godard P. Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium. Eur Respir J 1989, 2:202-209.
32. Laviolette M, Coulombe R, Picard S, Braquet P, Borgeat P. Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro. J Clin Invest 1986, 77:54-60. 10.1172/JCI112301, 423308, 3003154.
33. Sorensen D, Kelly T, Murray D, Nelson D. Corticosteroids stimulate an increase in phospholipase A2 inhibitor in human serum. J Steroid Biochem 1988, 29:271-273. 10.1016/0022-4731(88)90276-2, 3347066.
34. Sano A, Munoz N, Sano H, Choi J, Zhu X, Jacobs B, Leff A. Inhibition of cPLA2 Translocation and Leukotriene C4 Secretion by Fluticasone Propionate in Exogenously Activated Human Eosinophils. Am J Respir Crit Care Med 1999, 159:1903-1909.
35. Vachier I, Chavis C, Majori M, Farce M, Bousquet J, Godard P, Chanez P. Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma. Journal of Allergy and Clinical Immunology 2001, 107:824-831. 10.1067/mai.2001.113868, 11344349.
36. Yoss EB, Spannhake EW, Flynn JT, Fish JE, Peters SP. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Am J Respir Cell Mol Biol 1990, 2:69-80.
37. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994, 149:953-959.
38. Levy BD, Lukacs NW, Berlin AA, Schmidt B, Guilford WJ, Serhan CN, Parkinson JF. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 2007, 21:3877-3884. 10.1096/fj.07-8653com, 17625069.
39. Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S. Cyclooxygenase-lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: An imbalance between proinflammatory and antiinflammatory lipid mediators. Arthritis and rheumatism 2005, 52:3783-3791. 10.1002/art.21432, 16320329.
40. Mangino MJ, Brounts L, Harms B, Heise C. Lipoxin biosynthesis in inflammatory bowel disease. Prostaglandins and Other Lipid Mediators 2006, 79:84-92.
41. Lu MC, Peters-Golden M, Hostetler DE, Robinson NE, Derksen FJ. Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 1996, 271:L547-L554.
42. Gangemi S, Pescara L, D'Urbano E, Basile G, Nicita-Mauro V, Dav¥ G, Romano M. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Experimental Gerontology 2005, 40:612-614. 10.1016/j.exger.2005.04.004, 15935589.